ABBOTT PARK, Ill., Sept. 28, 2020 /PRNewswire/ -- Abbott (NYSE: ABT), the worldwide leader in continuous glucose monitoring (CGM) technology, 8 announced today it has secured CE Mark (Conformité ...

FreeStyle Libre 3 sensors will be phased out in the UK by the end of 2025, meaning that people living with diabetes who use the sensors will need to start using FreeStyle Libre 3 Plus sensors instead.

Glucose monitoring is key to effective diabetes management as it helps people living with diabetes understand how their body responds to food, exercise, and medications 3. It empowers them to take an ...

In a seemingly ongoing supply issue with FreeStyle Libre sensors, people with type 1 diabetes are struggling to get hold of replacement sensors for the blood glucose monitor. Pharmacy teams and ...

MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...

MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...